Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response

Journal of Virology

Volumn 76, Issue 1, 2002, Pages 127-135

  Molinier Frenkel, V ^a   Lengagne, R ^a   Gaden, F ^a   Hong, S S ^a   Choppin, J ^a   Gahery Segard H ^a   Boulanger, P ^a   Guillet, J G ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; EPITOPE; IMMUNOLOGICAL ADJUVANT; LIPOPEPTIDE; PROTEIN HEXON; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; EFFECTOR CELL; GENE THERAPY; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRION; VIRUS CAPSID; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNIZATION; INTERLEUKIN-2; LIPOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINATION, GENETIC; TH1 CELLS;

EID: 0036132850     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.1.127-135.2002     Document Type: Article

References (48)

1. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-κB
2. Characterization of adenovirus protein IX
3. Comparative optical properties of free and assembled hexon capsomeres of human adenovirus type 2
4. Large-scale preparation of soluble adenovirus hexon, penton and fiber antigens in highly purified form
5. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL
6. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression
7. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues
8. Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography
9. Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity
10. Humoral response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virusinduced Ig subclass shifts
11. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products
12. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type I lipopeptide vaccine
13. Adenovirus fiber protein (FP) functions as a mitogen and an adjuvant
14. Murine dendritic cells infected with adenovirus vectors show signs of activation
15. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver
16. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
17. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector
18. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
19. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy
20. Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells
21. Structural and functional determinants in adenovirus type 2 penton base recombinant protein
22. Characterization of a multi-lipopeptide mixture used as an HIV-1 vaccine candidate
23. Physicochemical characteristics of structural and non-structural proteins of human adenovirus 2
24. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted
25. The role of CD40/ CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells
26. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein
27. d through interactions between a glutamine at P3 and pocket D
28. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
29. Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes
30. Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients
31. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway
32. Hexon trimerization occurring in an assembly-defective, 100K temperature-sensitive mutant of adenovirus 2
33. + T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques
34. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo
35. The architecture of adenoviruses
36. Determination of the nucleotide sequence for the penton-base gene of human adenovirus type 5
37. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber
38. A recombinant human adenovirus vaccine against rabies
39. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset
40. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: Endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue
41. Type interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice
42. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides
43. Adenovirus fiber protein produces synthesis of interferon in mouse spleen and macrophage cultures
44. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
45. Nuclear import and export of viruses and virus genomes
46. Neutralization of adenoviruses: Kinetics, stoichiometry, and mechanisms
47. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
48. Cellular immunity to viral antigens limits E1 deleted adenoviruses for gene therapy